Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference

Frontiers in Behavioral Neuroscience

Volumn , Issue JANUARY 2012, 2012, Pages

  Voigt, Robin M ^a,b   Napier, T Celeste ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Addiction; Associative learning; Conditioned place preference; Methamphetamine; Mirtazapine; Psychostimulant

Indexed keywords

METHAMPHETAMINE; MIRTAZAPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; DRUG EFFICACY; DRUG MECHANISM; DRUG REEXPOSURE; MALE; NONHUMAN; PLACE PREFERENCE; RAT; SINGLE DRUG DOSE; STATE DEPENDENT LEARNING;

EID: 84856966015     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2011.00092     Document Type: Article

References (85)

1. Albert, P. R., and Tiberi, M. (2001). Receptor signaling and structure: insights from serotonin-1 receptors. Trends Endocrinol. Metab. 12, 453-460.
2. Arnsten, A. F., Ramos, B. P., Birn-baum, S. G., and Taylor, J. R. (2005). Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol. Med. 11, 121-128.
3. Bell, K., Duffy, P., and Kalivas, P. W. (2000). Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology 23, 335-344.
4. Bhanji, N. H., Margolese, H. C., Saint-Laurent, M., and Chouinard, G. (2002). Dysphoric mania induced by high-dose mirtazapine: a case for norepinephrine syndrome? Int. Clin. Psychopharmacol. 17, 319-322.
5. Boehm, S. (1999). Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses. J. Physiol. (Lond.) 519(Pt 2), 439-449.
6. Bourtchouladze, R., Abel, T., Berman, N., Gordon, R., Lapidus, K., and Kandel, E. R. (1998). Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn. Mem. 5, 365-374.
7. Brown, E. E., Robertson, G. S., and Fibiger, H. C. (1992). Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain lim-bic structures. J. Neurosci. 12,4112.
8. Childress, A. R., Ehrman, R. N., Wang, Z., Li, Y., Sciortino, N., Hakun, J., Jens, W., Suh, J., Listerud, J., Mar-quez, K., Franklin, T., Langleben, D., Detre, J., and O'Brien, C. P. (2008). Prelude to passion: limbic activation by unseen drug and sexual cues. PLoS ONE 3, e1506. doi:10.1371/journal.pone.0001506
9. Childress, A. R., Mozley, P. D., McEl-gin, W., Fitzgerald, J., Reivich, M., and O'Brien, C. P. (1999). Lim-bic activation during cue-induced cocaine craving. Am. J. Psychiatry 156, 11-18.
10. Childs, E., and deWit, H. (2009). Amphetamine-induced place preference in humans. Biol. Psychiatry 65, 900-904.
11. Ciccocioppo, R., Sanna, P. P., and Weiss, F. (2001). Cocaine-predictive stimulus induces drug-seeking behavior and neural activationinlimbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc. Natl. Acad. Sci. U.S.A. 98, 1976-1981.
12. Colfax, G. N., Santos, G. M., Das, M., Santos, D. M., Matheson, T., Gasper, J., Shoptaw, S., and Vit-tinghoff, E. (2011). Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch. Gen. Psychiatry 68, 1168-1175.
13. Cruickshank, C. C., Montebello, M. E., Dyer, K. R., Quigley, A., Blaszczyk, J., Tomkins, S., and Shand, D. (2008). A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. DrugAlcohol Rev. 27, 326-333.
14. Dai, H., Kaneko, K., Kato, H., Fujii, S., Jing, Y., Xu, A., Sakurai, E., Kato, M., Okamura, N., Kuramasu, A., and Yanai, K. (2007). Selective cognitive dysfunction in mice lacking hista-mine H1 and H2 receptors. Neurosci. Res. 57, 306-313.
15. de Boer, T. H. (1996). The pharmaco-logic profile of mirtazapine. J. Clin. Psychiatry 57(Suppl. 4), 19-25.
16. de Boer, T. H., Nefkens, F., vanHelvoirt, A., and VanDelft, A. M. (1996). Dif-ferencesinmodulationofnoradren-ergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J. Pharmacol. Exp. Ther. 277, 852-860.
17. Devivo, M., and Maayani, S. (1985). Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Eur. J. Pharmacol. 119, 231-234.
18. Di, G. G., Di, M. V., Pierucci, M., and Esposito, E. (2008). Serotonin-dopamine interaction: electrophys-iological evidence. Prog. Brain Res. 172, 45-71.
19. Dragunow, M., and Faull, R. (1989). The use of c-fos as a metabolic marker in neuronal pathwaytracing. JNeurosci. Methods 29, 261-265.
20. Dudai, Y. (2006). Reconsolidation: the advantage of being refocused. Curr. Opin. Neurobiol. 16, 174-178.
21. Ehrman, R. N., Robbins, S. J., Chil-dress, A. R., and O'Brien, C. P. (1992). Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl.) 107, 523-529.
22. Eidi, M., Zarrindast, M. R., Eidi, A., Oryan, S., and Parivar, K. (2003). Effects of histamine and cholin-ergic systems on memory retention of passive avoidance learning in rats. Eur. J. Pharmacol. 465, 91-96.
23. Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., and Ogren, S. O. (2008). 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur. J. Pharmacol. 596, 107-110.
24. Ferry, B., and McGaugh, J. L. (2008). Involvement of basolateral amygdala alpha2-adrenoceptors in modulating consolidation of inhibitory avoidance memory. Learn. Mem. 15, 238-243.
25. Franklin, T. R., and Druhan, J. P. (2000). ExpressionofFos-related antigensin the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. Eur. J. Neurosci. 12, 2097-2106.
26. Haapalinna, A., Sirvio, J., and Lam-mintausta, R. (1998). Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. Eur. J. Pharmacol. 347, 29-40.
27. Haddjeri, N., Blier, P., and de, M. C. (1995). Noradrenergic modulation of central serotonergic neu-rotransmission: acute and long-term actions of mirtazapine. Int. Clin. Psychopharmacol. 10(Suppl. 4), 11-17.
28. Haddjeri, N., Blier, P., and de, M. C. (1996). Effectofthe alpha-2 adreno-ceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J. Pharmacol. Exp. Ther. 277, 861-871.
29. Haddjeri, N., Blier, P., and De Mon-tigny, C. (1998a). Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J. Affect. Disord. 51,255-266.
30. Haddjeri, N., Blier, P., and De Montigny, C. (1998b). Long-term antidepres-sant treatments result in a tonic activation of forebrain 5-HT1A receptors. J. Neurosci. 18,10150-10156.
31. Harper, L. K., and Napier, T. C. (2005). Treatment with the antidepressant mirtazapine negates conditioned place preference and motor sensiti-zation established bymethampheta-mine. Abstr. Soc. Neurosci. 31, 75.9.
32. Hartz, D. T., Frederick-Osborne, S. L., and Galloway, G. P. (2001). Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend. 63, 269-276.
33. Hasenohrl, R. U., Kuhlen, A., Frisch, C., Galosi, R., Brandao, M. L., and Huston, J. P. (2001). Comparison of intra-accumbens injection of histamine with histamine H1-receptor antagonist chlorpheni-ramine in effects on reinforcement and memory parameters. Behav. Brain Res. 124, 203-211.
34. Herrold, A. A., Shen, F., Graham, M. P., Harper, L. K., Specio, S. E., Tedford, C. E., and Napier, T. C. (2009). Mir-tazapine treatment after conditioning with methamphetamine alters subsequent expressionofplace preference. Drug Alcohol Depend. 99, 231-239.
35. Hotsenpiller, G., Giorgetti, M., and Wolf, M. E. (2001). Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur. J. Neurosci. 14, 1843-1855.
36. Hotsenpiller, G., and Wolf, M. E. (2002). Extracellular glutamate levels in pre-frontal cortex during the expression of associative responses to cocaine related stimuli. Neuropharmacology 43, 1218-1229.
37. Isiegas, C., Park, A., Kandel, E. R., Abel, T., and Lattal, K. M. (2006). Transgenic inhibition of neuronal protein kinase A activity facilitates fear extinction. J. Neurosci. 26, 12700-12707.
38. Jakobs, K. H., and Schultz, G. (1982). Signal transformation involving alpha-adrenoceptors. J. Cardiovasc. Pharmacol. 4(Suppl. 1), S63-S67.
39. Kang, L., Wang, D., Li, B., Hu, M., Zhang, P., and Li, J. (2008). Mirtazapine, a noradrenergic and specific sero-tonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats. Am. J. Drug Alcohol Abuse 34, 541-552.
40. Kawahara, H., Kawahara, Y., and Westerink, B. H. (2001). The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur. J. Pharmacol. 418, 177-186.
41. Kilts, C. D., Gross, R. E., Ely, T. D., and Drexler, K. P. (2004). The neural correlates of cue-induced craving in cocaine-dependent women. Am. J. Psychiatry 161, 233-241.
42. Kilts, C. D., Schweitzer, J. B., Quinn, C. K., Gross, R. E., Faber, T. L., Muhammad, F., Ely, T. D., Hoffman, J. M., and Drexler, K. P. (2001). Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 58, 334-341.
43. Kongsakon, R., Papadopoulos, K. I., and Saguansiritham, R. (2005). Mirtazapine in amphetamine detoxification: a placebo-controlled pilotstudy. Int. Clin. Psychopharmacol. 20,253-256.
44. Lanfumey, L., and Hamon, M. (2004). 5-HT1 receptors. Curr. DrugTargets CNS Neurol. Disord. 3,1-10.
45. Lee, J. L., Milton, A. L., and Everitt, B. J. (2006). Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsoli-dation. J. Neurosci. 26, 5881-5887.
46. Lin, S. K., Pan, W. H., and Yeh, P. H. (2007). Prefrontal dopamine efflux during exposure to drug-associated contextual cues in rats with prior repeated methamphetamine. Brain Res. Bull. 71,365-371.
47. Maura, G., Roccatagliata, E., Ulivi, M., and Raiteri, M. (1988). Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 145,31-38.
48. McDaid, J., Graham, M. P., and Napier, T. C. (2006). Methamphetamine-induced sensitization differentially alters pCREB and AFosB throughtout the limbic circuit of the mammalian brain. Mol. Pharmacol. 70, 2064-2074.
49. McDaid, J., Tedford, C. E., Mackie, A. R., Dallimore, J. E., Mickiewicz, A. L., Shen, F., Angle, J. M., and Napier, T. C. (2007). Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations ofdopaminergicandseroton-ergic ligands in methamphetamine-sensitized rats. DrugAlcohol Depend. 86, 55-66.
50. McGaugh, J. L. (2000). Memory-a century of consolidation. Science 287, 248-251.
51. McGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., and White, J. M. (2008). Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J. Subst. Abuse Treat. 35, 334-342.
52. Meneses, A. (2007a). Do serotonin(1-7) receptors modulate short and long-term memory? Neurobiol. Learn. Mem. 87,561-572.
53. Meneses, A. (2007b). Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory. Behav. Brain Res. 184, 81-90.
54. Meneses, A., and Hong, E. (1999). 5-HT1A receptors modulate the con-solidationoflearning innormal and cognitivelyimpaired rats. Neurobiol. Learn. Mem. 71, 207-218.
55. Meneses, A., and Perez-Garcia, G. (2007). 5-HT(1A) receptors and memory. Neurosci. Biobehav. Rev. 31, 705-727.
56. Micheau, J., and Riedel, G. (1999). Protein kinases: which one is the memory molecule? Cell.Mol.LifeSci. 55, 534-548.
57. Milekic, M. H., Brown, S. D., Castellini, C., and Alberini, C. M. (2006). Persistent disruption of an established morphine conditioned place preference. J. Neurosci. 26, 3010-3020.
58. Miller, C. A., and Marshall, J. F. (2005). Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47, 873-884.
59. Morgan, J. I., and Curran, T. (1989). Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 12, 459-462.
60. National Research Council. (1996). Front matter, in Guide for the Care and Use of Laboratory Animals (Washington: National Academies Press), 1.
61. O'Brien, C. P., Childress, A. R., Ehrman, R., and Robbins, S. J. (1998). Conditioning factors in drug abuse: can they explain compulsion? J. Psy-chopharmacol. 12, 15-22.
62. O'Brien, C. P., Childress, A. R., McLel-lan, A. T., and Ehrman, R. (1992). Classical conditioning in drug-dependent humans. Ann. N. Y. Acad. Sci. 654, 400-415.
63. Olvera-Cortes, M. E., Anguiano-Rod-riguez, P., Lopez-Vazquez, M. A., and Alfaro, J. M. (2008). Serotonin/ dopamine interaction in learning. Prog. Brain Res. 172,567-602.
64. Pierce, R. C., and Kalivas, P. W. (1997). A circuitry model of the expression of behavioral sensiti-zation to amphetamine-like psy-chostimulants. Brain Res. Rev. 25, 192-216.
65. Quevedo, J., Vianna, M. R., Martins, M. R., Barichello, T., Medina, J. H., Roesler, R., and Izquierdo, I. (2004). Protein synthesis, PKA, and MAP kinase are differentially involved in short- and long-term memory in rats. Behav. Brain Res. 154, 339-343.
66. Rademacher, D. J., Kovacs, B., Shen, F., Napier, T. C., and Meredith, G. E. (2006). The neural substrates of amphetamine conditioned place preference: implications for the formation of conditioned stimulus-reward associations. Eur. J. Neurosci. 24, 2089-2097.
67. Rafeyan, R., and Napier, T. C. (2008). Clinical evidence for the utility of mirtazapine for relapse prevention in humans dependent upon stimulants and/or opiates. Abstr. Soc. Neurosci. 34, 661.1.
68. Rebec, G. V., and Sun, W. (2005). Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontalcortex. J.Exp.Anal.Behav. 84, 653-666.
69. Rhodes, J. S., Ryabinin, A. E., and Crabbe, J. C. (2005). Patterns of brainactivationassociatedwithcon-textual conditioning to metham-phetamine in mice. Behav. Neurosci. 119, 759-771.
70. Sagar, S. M., Sharp, F. R., and Cur-ran, T. (1988). Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240, 1328-1331.
71. Sax, K.W., and Strakowski, S.M. (2001). Behavioral sensitization in humans. J. Addict. Dis. 20, 55-65.
72. Schoeffter, P., and Hoyer, D. (1988). Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95, 975-985.
73. Shen, F., Meredith, G. E., and Napier, T. C. (2006). Amphetamine-induced place preference and conditioned motor sensitization requires activation of tyrosine kinase receptors in the hippocampus. J. Neurosci. 26, 11041-11051.
74. Shoptaw, S. J., Kao, U., Heinzerling, K., and Ling, W. (2009). Treatment for amphetamine withdrawal. Cochrane Database Syst. Rev. 15, CD003021.
75. Tronson, N. C., and Taylor, J. R. (2007). Molecular mechanisms of memory reconsolidation. Nat. Rev. Neurosci. 8, 262-275.
76. Tzschentke, T. M. (1998). Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neu-robiol. 56, 613-672.
77. Tzschentke, T. M. (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12, 227-462.
78. Valjent, E., Corbille, A. G., Bertran-Gonzalez, J., Herve, D., and Girault, J.A.(2006). InhibitionofERKpath-wayorproteinsynthesisduringreex-posure to drugs of abuse erases previously learned place preference. Proc. Natl. Acad. Sci. U.S.A. 103, 2932-2937.
79. Vianna, M. R., Izquierdo, L. A., Bar-ros, D. M., Ardenghi, P., Pereira, P., Rodrigues, C., Moletta, B., Medina, J. H., and Izquierdo, I. (2000). Differential role of hip-pocampal cAMP-dependent protein kinase in short- and long-term memory. Neurochem. Res. 25, 621-626.
80. Voigt, R. M., Herrold, A. A., and Napier, T. C. (2011a). Baclofenfacilitatesthe extinction of methamphetamine-induced conditioned place preference in rats. Behav. Neurosci. 125, 261-267.
81. Voigt, R. M., Mickiewicz, A. L., and Napier, T. C. (2011b). Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats. Behav. Brain Res. 225, 91-96.
82. Voigt, R. M., and Napier, T. C. (2007). Systemic baclofen blocks the expression of methamphetamine-induced conditioned place preference: implications for GABAB receptors in the medial dorsal thala-mus. Abstr. Soc. Neurosci. 33, 916.16.
83. Zlomuzica, A., Ruocco, L. A., Sadile, A. G., Huston, J. P., and Dere, E. (2009). Histamine H1 recep- tor knockout mice exhibit impaired spatial memory in the eight-arm radial maze. Br. J. Pharmacol. 157, 86-91.
84. Zombeck, J. A., Chen, G. T., Johnson, Z. V., Rosenberg, D. M., Craig, A. B., and Rhodes, J. S. (2008). Neu-roanatomical specificity of conditioned responses to cocaine versus food in mice. Physiol. Behav. 93, 637-650.
85. Zueco Perez, P. L. (2002). Mirtazapine in the treatment of cocaine-dependence in patients with methadone. Actas Esp. Psiquiatr. 30, 337-342.